Drug Therapy

Daniel J. Clauw, MD
Associate Professor of Medicine and Orthopaedics, Georgetown University Medical Center,Washington, DC

Address: Daniel J. Clauw, MD, Georgetown University Medical Center, 3800 Reservoir Rd, Washington, DC 20007

Dr. Clauw serves as a consultant for and has received grant or research support from Cypress Biosciences.

This article discusses therapies that are not yet approved by the US Food and Drug Administration for the use under discussion.

Daniel J. Clauw, MD
Associate Professor of Medicine and Orthopaedics, Georgetown University Medical Center,Washington, DC

Address: Daniel J. Clauw, MD, Georgetown University Medical Center, 3800 Reservoir Rd, Washington, DC 20007

Dr. Clauw serves as a consultant for and has received grant or research support from Cypress Biosciences.

This article discusses therapies that are not yet approved by the US Food and Drug Administration for the use under discussion.

Daniel J. Clauw, MD
Associate Professor of Medicine and Orthopaedics, Georgetown University Medical Center,Washington, DC

Address: Daniel J. Clauw, MD, Georgetown University Medical Center, 3800 Reservoir Rd, Washington, DC 20007

Dr. Clauw serves as a consultant for and has received grant or research support from Cypress Biosciences.

This article discusses therapies that are not yet approved by the US Food and Drug Administration for the use under discussion.

Steven D. Mawhorter, MD
Department of Infectious Diseases, Cleveland Clinic

Address: Steven D. Mawhorter, MD, Department of Infectious Diseases, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

This paper discusses treatments that are ‘‘off label,” ie, not approved by the Food and Drug Administration for the use under discussion.

Steven D. Mawhorter, MD
Department of Infectious Diseases, Cleveland Clinic

Address: Steven D. Mawhorter, MD, Department of Infectious Diseases, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

This paper discusses treatments that are ‘‘off label,” ie, not approved by the Food and Drug Administration for the use under discussion.

Steven D. Mawhorter, MD
Department of Infectious Diseases, Cleveland Clinic

Address: Steven D. Mawhorter, MD, Department of Infectious Diseases, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

This paper discusses treatments that are ‘‘off label,” ie, not approved by the Food and Drug Administration for the use under discussion.

Cindy L. Moore, MS, RD, LD
Director, Department of Nutrition Therapy, Cleveland Clinic

Cindy L. Moore, MS, RD, LD
Director, Department of Nutrition Therapy, Cleveland Clinic

Cindy L. Moore, MS, RD, LD
Director, Department of Nutrition Therapy, Cleveland Clinic

George L. Blackburn, MD, PhD
Associate Professor of Surgery and Nutrition, S. Daniel Abraham Chair in Nutrition Medicine, Associate Director of Nutrition, Division of Nutrition, Harvard Medical School; Director, Nutrition Support Service, Director, Center for the Study of Nutrition Medicine; Program Director, Surgical Therapy for Severe Obesity; Chief, Nutrition Metabolism Laboratory, Beth Israel Deaconess Medical Center, Boston

Judy C.C. Phillips, MS, RD
Program Manager, Center for Nutritional Research Charitable Trust; Content Manager, Centers for Obesity Research and Education,Wellesley, MA

Susan Morreale, CHES
Project Manager, Center for Nutritional Research Charitable Trust; Program Coordinator, Centers for Obesity Research and Education,Wellesley, MA

Address: George L. Blackburn, MD, PhD, Beth Israel Deaconess Medical Center, 1 Autumn Street, Kennedy 152, Boston, MA 02215; [email protected]

George L. Blackburn, MD, PhD
Associate Professor of Surgery and Nutrition, S. Daniel Abraham Chair in Nutrition Medicine, Associate Director of Nutrition, Division of Nutrition, Harvard Medical School; Director, Nutrition Support Service, Director, Center for the Study of Nutrition Medicine; Program Director, Surgical Therapy for Severe Obesity; Chief, Nutrition Metabolism Laboratory, Beth Israel Deaconess Medical Center, Boston

Judy C.C. Phillips, MS, RD
Program Manager, Center for Nutritional Research Charitable Trust; Content Manager, Centers for Obesity Research and Education,Wellesley, MA

Susan Morreale, CHES
Project Manager, Center for Nutritional Research Charitable Trust; Program Coordinator, Centers for Obesity Research and Education,Wellesley, MA

Address: George L. Blackburn, MD, PhD, Beth Israel Deaconess Medical Center, 1 Autumn Street, Kennedy 152, Boston, MA 02215; [email protected]

George L. Blackburn, MD, PhD
Associate Professor of Surgery and Nutrition, S. Daniel Abraham Chair in Nutrition Medicine, Associate Director of Nutrition, Division of Nutrition, Harvard Medical School; Director, Nutrition Support Service, Director, Center for the Study of Nutrition Medicine; Program Director, Surgical Therapy for Severe Obesity; Chief, Nutrition Metabolism Laboratory, Beth Israel Deaconess Medical Center, Boston

Judy C.C. Phillips, MS, RD
Program Manager, Center for Nutritional Research Charitable Trust; Content Manager, Centers for Obesity Research and Education,Wellesley, MA

Susan Morreale, CHES
Project Manager, Center for Nutritional Research Charitable Trust; Program Coordinator, Centers for Obesity Research and Education,Wellesley, MA

Address: George L. Blackburn, MD, PhD, Beth Israel Deaconess Medical Center, 1 Autumn Street, Kennedy 152, Boston, MA 02215; [email protected]